default author photo

Nicholas Simon

Government of the United States of America - Center for Cancer Research

Bethesda, MD 20892

United States

SCHOLARLY PAPERS

1

DOWNLOADS

114

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Final Results from a Phase 1 Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or with Ipilimumab for Advanced/Metastatic Genitourinary Tumours

Number of pages: 73 Posted: 26 Jun 2023
National Institutes of Health (NIH) - Bladder Cancer Section, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Biostatistics and Data Management Section, National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Laboratory of Translational Genomics, Government of the United States of America - Center for Cancer Research, National Institutes of Health (NIH) - Laboratory of Pathology, Government of the United States of America - Laboratory of Pathology, Government of the United States of America - Laboratory of Pathology, Government of the United States of America - Clinical Center, Government of the United States of America - Clinical Center, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - Division of Cancer Prevention, National Institutes of Health (NIH) - Clinical Immunotherapy Section, Rutgers University, New Brunswick - Rutgers Cancer Institute of New Jersey, City of Hope - Comprehensive Cancer Center, University of Southern California, Columbia University - Herbert Irving Comprehensive Cancer Center, University of California, Davis - Comprehensive Cancer Center, Government of the United States of America - Center for Cancer Research and Ohio State University (OSU) - Department of Internal Medicine
Downloads 114 (621,896)

Abstract:

Loading...

Urothelial Carcinoma, Rare Genitourinary Tumours, Immunotherapy, Immune Correlates Of Antitumor Response, Renal Medullary Carcinoma, Bladder Squamous Cell Carcinoma, Squamous Cell Carcinoma Of The Penis, Bladder Adenocarcinoma, Urachal Carcinoma, Cabozantinib